Genetic alterations in the phosphatidylinositol 3-kinase (PI3K)/V-AKT murine thymoma viral oncogene homolog (AKT)/mechanistic target of rapamycin (MTOR) pathway are common events in breast cancer [4, 5]. This evidence concerns the gene PIK3CA and breast cancer.